Search Options Stock News and Analysis from Schaeffer's

2 Biotech Stocks Options Traders Are Watching

https://www.schaeffersresearch.com/content/options/2023/03/06/2-biotech-stocks-options-traders-are-watching

3/6/2023 1:36 PM

At least two biotech stocks are seeing increased scrutiny in the options pits, with BridgeBio Pharma Inc (NASDAQ:BBIO) and Esperion Therapeutics Inc (NASDAQ:ESPR) moving in opposite directions follo...

2 Biotech Stocks Options Traders Love Today

https://www.schaeffersresearch.com/content/options/2022/12/07/2-biotech-stocks-options-traders-love-today

12/7/2022 12:16 PM

At least two biotech stocks are triggering an options trading frenzy today, with Prometheus Biosciences Inc (NASDAQ:RXDX) and Esperion Therapeutics Inc (NASDAQ:ESPR) moving in opposite directions foll...

2 Drug Stocks Dinged by Goldman Downgrades

https://www.schaeffersresearch.com/content/analysis/2019/05/29/2-drug-stocks-dinged-by-goldman-downgrades

5/29/2019 12:56 PM

This morning, Goldman Sachs weighed in on two pharma stocks, downgrading Clovis Oncology Inc (NASDAQ:CLVS) and Esperion Therapeutics Inc (NASDAQ:ESPR) to "sell." Regarding the former, Goldman believes...

2 Red-Hot Drug Stocks Squeezing Shorts

https://www.schaeffersresearch.com/content/news/2019/05/06/2-red-hot-drug-stocks-squeezing-shorts

5/6/2019 9:55 AM

Near the top of the Nasdaq today sits Esperion Therapeutics Inc (NASDAQ:ESPR), after the Food and Drug Administration (FDA) accepted marketing applications for the company's cholesterol drug. At last...

3 Drug Stocks Near the Bottom of the Nasdaq Today

https://www.schaeffersresearch.com/content/news/2018/05/02/3-drug-stocks-near-the-bottom-of-the-nasdaq-today

5/2/2018 3:22 PM

The Nasdaq is outperforming today, thanks to a positive earnings reaction for Apple (AAPL). Nevertheless, drug stocks Akorn, Inc. (NASDAQ:AKRX), Esperion Therapeutics Inc (NASDAQ:ESPR), and Gilead Sc...

PEOPLE ALSO SEARCH FOR